BioSpace News Archive

U.S. Patent and Trademark Office issued three U.S. patents covering certain anti-CD137 antibodies, including its lead therapeutic candidate, CTX-471.

Highlights the Multiple Ways Peter Crowley and Michael Kishbauch have Failed Stockholders While the Board Disingenuously Touts its “Significant Progress” and Self-Proclaimed Mastery

Dr. Christa Clark is honored to offer the $2,500 “Supporting & Promoting Real Opportunities for Women to Thrive” scholarship for a third year.

vybe urgent care, the leading independent operator of urgent care centers in greater Philadelphia, announces the opening of its newest location in the Spring Garden District of Philadelphia.

Commonwealth Psychology Associates®, an award-winning private behavioral health center, announced the opening of its newest location near North Station.

In total, 19 abstracts were presented on Baxter’s therapy options

Advanced Data Systems Corp., a leading national provider of facility-based clinical substance abuse revenue cycle management, and patient workflow solutions for behavioral health and addiction treatment centers, participated and presented in panel discussions at Behavioral Health Resources’ EMP Series on the real world challenges faced by addiction disorder treatment organizations.

Candel Therapeutics (a.k.a. Advantagene, Inc.) announced that it has completed enrollment of the “ULYSSES” trial, a Phase 2 study of ProstAtak® for prostate cancer patients choosing Active Surveillance (PrTK04- NCT02768363).

American Well®, a leading U.S. telehealth company, today announced the recipients of its annual Client Awards

Almirall announced today their partnership with the American Acne and Rosacea Society to highlight the global health burden of acne during National Acne Awareness Month in June.